Related Experiment Video
Updated: Jun 28, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
Elevated stress-hemoconcentration in major depression is normalized by antidepressant treatment: secondary analysis
Ma-Li Wong1, Chuanhui Dong, Karin Esposito
1Department of Psychiatry and Behavioral Sciences, Leonard M. Miller School of Medicine, University of Miami, Miami, Florida, USA. mali@miami.edu
Insights
Major depressive disorder (MDD) is linked to increased stress-hemoconcentration and blood viscosity. Antidepressant treatment improved these measures, suggesting a potential benefit for cardiovascular health in patients with depression.
Area of Science:
- Cardiology
- Psychiatry
- Hematology
Background:
- Major depressive disorder (MDD) is an independent risk factor for cardiovascular disease (CVD).
- MDD presence in CVD patients correlates with worse cardiac outcomes after myocardial infarction (MI).
- Stress-hemoconcentration, a potential CVD risk factor from psychological stress, is not well-studied in MDD.
Purpose of the Study:
- To investigate stress-hemoconcentration in individuals with mild to moderate MDD.
- To assess the impact of antidepressant treatment on stress-hemoconcentration and blood viscosity in MDD patients.
Main Methods:
- Secondary analysis of data from a pharmacogenetic study.
- Inclusion of controls and subjects with mild to moderate MDD.
- Measurement of hematologic and hemorheologic markers, including blood cell counts, hematocrit, hemoglobin, total serum protein, albumin, and whole blood viscosity.
Main Results:
- Individuals with MDD exhibited significantly higher hemorheologic measures and blood viscosity compared to controls.
- These measures correlated with depression severity.
- Antidepressant treatment for 8 weeks led to significant improvements in stress-hemoconcentration measures, including white blood cell count, red blood cell measures, and plasma volume, which correlated with reduced depression severity.
Conclusions:
- Stress-hemoconcentration is present in mild to moderate MDD patients at baseline.
- Antidepressant treatment improves hemorheologic measures and correlates with depression symptom improvement.
- These findings suggest antidepressants may reduce cardiovascular risk by improving blood viscosity in depressed patients.
Background:
Major depressive disorder (MDD) is an independent risk factor for cardiovascular disease (CVD); the presence of MDD symptoms in patients with CVD is associated with a higher incidence of cardiac complications following acute myocardial infarction (MI). Stress-hemoconcentration, a result of psychological stress that might be a risk factor for the pathogenesis of CVD, has been studied in stress-challenge paradigms but has not been systematically studied in MDD.
Methods:
Secondary analysis of stress hemoconcentration was performed on data from controls and subjects with mild to moderate MDD participating in an ongoing pharmacogenetic study of antidepressant treatment response to desipramine or fluoxetine. Hematologic and hemorheologic measures of stress-hemoconcentration included blood cell counts, hematocrit, hemoglobin, total serum protein, and albumin, and whole blood viscosity.
Findings:
Subjects with mild to moderate MDD had significantly increased hemorheologic measures of stress-hemoconcentration and blood viscosity when compared to controls; these measures were correlated with depression severity. Measures of stress-hemoconcentration improved significantly after 8 weeks of antidepressant treatment. Improvements in white blood cell count, red blood cell measures and plasma volume were correlated with decreased severity of depression.
Conclusions:
Our secondary data analyses support that stress-hemoconcentration, possibly caused by decrements in plasma volume during psychological stress, is present in Mexican-American subjects with mild to moderate MDD at non-challenged baseline conditions. We also found that after antidepressant treatment hemorheologic measures of stress-hemoconcentration are improved and are correlated with improvement of depressive symptoms. These findings suggest that antidepressant treatment may have a positive impact in CVD by ameliorating increased blood viscosity. Physicians should be aware of the potential impact of measures of hemoconcentration and consider the implications for cardiovascular risk in depressed patients.
More Related Videos
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Depression: Overview
Antidepressant Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Introduction to Stress and Lifestyle

